Gene · 9134
Papers2,792
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,792
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1/Hippo signaling pathway. | Sci China Life Sci | 2025 | 39754006 | PubTator, text mining | PubMed |
| An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes. | Nat Chem Biol | 2025 | 39294320 | PubTator, text mining | PubMed |
| Role of sodium-dependent vitamin C transporter 2 in human periodontal ligament fibroblasts. | J Periodontal Res | 2025 | 39225294 | PubTator, text mining | PubMed |
| Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer. | Front Endocrinol (Lausanne) | 2024 | 39698031 | PubTator, text mining | PubMed |
| ELF3 Overexpression Contributes to the Malignant Transformation of HPV16 E6/E7-Immortalized Keratinocytes by Promoting CCNE2 Expression. | J Microbiol Biotechnol | 2024 | 39572025 | PubTator, text mining | PubMed |
| Comprehensive cataloging of miR-363 as a therapeutic & non-invasive biomarker of prostate cancer. | Indian J Med Res | 2024 | 39513205 | PubTator, text mining | PubMed |
| Zanthoxylum alkylamides alleviate cell cycle arrest and oxidative stress to retard d-galactose-induced aging. | Food Sci Biotechnol | 2024 | 39493387 | PubTator, text mining | PubMed |
| Targeting CDK2 to combat drug resistance in cancer therapy. | Future Oncol | 2024 | 39469865 | PubTator, text mining | PubMed |
| Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest. | J Exp Clin Cancer Res | 2024 | 39415286 | PubTator, text mining | PubMed |
| Elucidating the molecular interactions and immune modulation of bisphenols exposure in the pathogenesis of polycystic ovary syndrome. | Reprod Toxicol | 2024 | 39313041 | PubTator, text mining | PubMed |
| Stable laminar shear stress induces G1 cell cycle arrest and autophagy in urothelial carcinoma by a torque sensor-coupled cone-and-plate device. | Eur J Cell Biol | 2024 | 39217678 | PubTator, text mining | PubMed |
| Analysis of miR-497/195 cluster identifies new therapeutic targets in cervical cancer. | BMC Res Notes | 2024 | 39095857 | PubTator, text mining | PubMed |
| Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma. | Discov Oncol | 2024 | 38981878 | PubTator, text mining | PubMed |
| SLPI overexpression in hMSCs could be implicated in the HSC gene expression profile in AML. | Sci Rep | 2024 | 38969699 | PubTator, text mining | PubMed |
| Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes. | Front Endocrinol (Lausanne) | 2024 | 38915894 | PubTator, text mining | PubMed |
| FOXK2 amplification promotes breast cancer development and chemoresistance. | Cancer Lett | 2024 | 38901667 | PubTator, text mining | PubMed |
| Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer. | PLoS One | 2024 | 38820302 | PubTator, text mining | PubMed |
| Retraction: miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2. | PLoS Genet | 2024 | 38713643 | PubTator, text mining | PubMed |
| Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer. | Aging (Albany NY) | 2024 | 38643462 | PubTator, text mining | PubMed |
| Differential whole-genome doubling based signatures for improvement on clinical outcomes and drug response in patients with breast cancer. | Heliyon | 2024 | 38576569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9134/papers?page=4